Case Name: NOVARTIS PHARMACEUTICALS CORPORATION, Plaintiff-Appellee, v. MYLAN PHARMACEUTICALS INC. and Mylan Inc., Defendants-Appellants
Court: United States Court of Appeals for the Federal Circuit
Jurisdiction: United States
Decision Date: 2011-12-06
Citations: 440 F. App'x 924
Docket Number: No. 2011-1203
Parties: NOVARTIS PHARMACEUTICALS CORPORATION, Plaintiff-Appellee, v. MYLAN PHARMACEUTICALS INC. and Mylan Inc., Defendants-Appellants.
Judges: 
Reporter: West's Federal Appendix
Volume: 440
Pages: 924–925

Head Matter:
NOVARTIS PHARMACEUTICALS CORPORATION, Plaintiff-Appellee, v. MYLAN PHARMACEUTICALS INC. and Mylan Inc., Defendants-Appellants.
No. 2011-1203.
United States Court of Appeals, Federal Circuit.
Dec. 6, 2011.
Larry L. Shatzer, Seth C. Silber, Wilson, Sonsini, Goodrich & Rosati, Washington, DC, Terrence J.P. Kearney, Ron E. Shulman, Richard G. Frenkel, Latham & Watkins LLP, Menlo Park, CA, Joshua Alan Chester Mack, Wilson, Sonsini, Goodrich & Rosati, San Diego, CA, for Defendants-Appellants.
Nicholas N. Kallas, Diego Scambia, Christopher Earl Loh, Fitzpatrick, Celia, Harper & Scinto, New York, NY, for Plaintiff-Appellee.

Opinion:
ON MOTION
ORDER
Mylan Pharmaceuticals Inc. and Mylan Inc. move to dismiss their appeal.
Upon consideration thereof,
It Is Ordered That:
(1) The motion is granted. The appeal is dismissed.
(2) Each side shall bear its own costs.